P2RX7 and metabolic dysfunction-associated steatohepatitis: In addition, future studies will address the effects of lipotoxicity in the liver, a key step in NASH progression, by studying how fat accumulation and high levels of different saturated and unsaturated fatty acids in the liver may affect P2RX7 signaling pathway and altering homeostasis in different liver resident cells.